GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level

A popular GLP-1 ingredient is currently being recalled nationwide due to significant sterility concerns. This specific ingredient is used in medications such as Mounjaro and Zepbound. Consequently, the risk level associated with this recall has been raised to the second-highest level. Patients are advised to determine if their specific medication is impacted by this action to ensure safety and proper treatment while the recall process is managed across the country for these GLP-1 drugs.